PeerVoice Endocrinology & Metabolic Disorders Video PeerVoice
-
- Science
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
-
- video
Alex Abitbol, MDCM, FRCPC - Next Generation Basal Insulins: From Once Daily to Once Weekly Injections
Visit https://www.peervoice.com/JPS860 to view the entire programme with slides. After completing “Alex Abitbol, MDCM, FRCPC - Next Generation Basal Insulins: From Once Daily to Once Weekly Injections”, participants will be able to: Discuss the latest clinical evidence with existing and emerging long-acting basal insulin analogues in the treatment of patients with type 2 diabetes (T2D); Identify steps for successful basal insulin analogue therapy, including proper initiation and patient education; and Outline effective strategies for glucose monitoring in patients on basal insulin, including how to use continuous glucose monitoring to optimize T2D management.
-
- video
Alice YY Cheng, MD, FRCPC - Addressing Unmet Needs in Patients With T2D and CKD: Stepping Up Care to Improve Cardiorenal Outcomes
Visit https://www.peervoice.com/ETM860 to view the entire programme with slides. After completing “Alice YY Cheng, MD, FRCPC - Addressing Unmet Needs in Patients With T2D and CKD: Stepping Up Care to Improve Cardiorenal Outcomes”, participants will be able to: Outline morbidity and mortality risks for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) and current unmet needs in this patient population; Discuss best practices to identify and assess risk in patients with T2D and early CKD in primary care; Evaluate the role of non-steroidal mineralocorticoid receptor antagonist (nsMRA) therapy in the context of current treatment options for patients with T2D and CKD; and Apply best practices to monitor response and mitigate or manage safety concerns in patients receiving nsMRA therapy.
-
- video
Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes
Visit https://www.peervoice.com/QKR860 to view the entire programme with slides. After completing “Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes”, participants will be able to: Use recommended screening tests to identify chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM); Evaluate current efficacy and safety evidence guiding the use of novel treatments for CKD in T2DM; and Apply best practices for the initiation and management of novel therapies for treatment of CKD and T2DM.
-
- video
George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action
Visit https://www.peervoice.com/BSG860 to view the entire programme with slides. After completing “George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action”, participants will be able to: Summarise the evidence supporting the need for the current 2024 COVID-19 vaccination campaign for older adults and vulnerable individuals; and Outline the key recommendations by the World Health Organization (WHO) and European Centre for Disease Prevention and Control (ECDC) on the current 2024 COVID-19 vaccination roll-out.
-
- video
Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can
Visit https://www.peervoice.com/HPE860 to view the entire programme with slides. After completing “Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can”, participants will be able to: Apply best practices for the screening and formal diagnosis of obesity as a chronic disease; Identify patients who would benefit from treatment or referral for management of obesity; and Evaluate current and emerging strategies for treating obesity as a chronic disease.
-
- video
Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting
Visit https://www.peervoice.com/TBP860 to view the entire programme with slides. After completing “Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care Setting”, participants will be able to: Discuss the pathogenesis and metabolic drivers of metabolic dysfunction-associated steatohepatitis (MASH); Apply risk stratification scores for liver fibrosis; and Develop guideline-recommended management plans for patients with MASH.